NDC 62332-514

Treprostinil

Treprostinil

Treprostinil is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is Treprostinil.

Product ID62332-514_640d13cf-e774-4d34-8c81-3410f9724130
NDC62332-514
Product TypeHuman Prescription Drug
Proprietary NameTreprostinil
Generic NameTreprostinil
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2021-02-11
Marketing CategoryANDA / ANDA
Application NumberANDA211574
Labeler NameAlembic Pharmaceuticals Inc.
Substance NameTREPROSTINIL
Active Ingredient Strength20 mg/20mL
Pharm ClassesProstacycline Vasodilator [EPC],Prostaglandins I [CS],Vasodilation [PE]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 62332-514-20

1 VIAL in 1 CARTON (62332-514-20) > 20 mL in 1 VIAL
Marketing Start Date2021-02-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Treprostinil" or generic name "Treprostinil"

NDCBrand NameGeneric Name
0703-0666TreprostinilTreprostinil
0703-0676TreprostinilTreprostinil
0703-0686TreprostinilTreprostinil
0703-0696TreprostinilTreprostinil
0781-3420Treprostiniltreprostinil
0781-3425Treprostiniltreprostinil
0781-3427Treprostiniltreprostinil
0781-3430Treprostiniltreprostinil
42023-206TreprostinilTreprostinil
42023-207TreprostinilTreprostinil
42023-208TreprostinilTreprostinil
42023-209TreprostinilTreprostinil
62332-514TreprostinilTreprostinil
62332-515TreprostinilTreprostinil
62332-516TreprostinilTreprostinil
62332-517TreprostinilTreprostinil
66302-300Orenitramtreprostinil
66302-101Remodulintreprostinil
66302-102Remodulintreprostinil
66302-105Remodulintreprostinil
66302-110Remodulintreprostinil
66302-206TYVASOtreprostinil

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.